AI-generated summary
The authors review evidence on managing premyopia, a stage before myopia develops, in China. They cover biometric predictors such as axial length and hyperopic reserve, several interventions including outdoor time, optical lenses, low-concentration atropine and repeated low-level red-light therapy, and a risk-stratified framework. The abstract notes that compliance, safety and regulatory approval remain challenges for some treatments.
- Who or what was studied
- Children and young people in China with premyopia, defined as spherical equivalent refraction of +0.75 D or less and greater than -0.50 D.
- Limits stated in the abstract
- The abstract describes a narrative review and does not report pooled numbers, study counts or effect sizes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Myopia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.